Related Experiment Video
Updated: Feb 6, 2026

Exploring Life History Choices: Using Temperature and Substrate Type as Interacting Factors for Blowfly Larval and Female Preferences
Published on: November 17, 2023
Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates
Manjuan Liu1, Aurélie Mallinger1, Marcello Tortorici1
1Cancer Research UK Cancer Therapeutics Unit , The Institute of Cancer Research , London SM2 5NG , U.K.
Abstract:
APOBEC3B (A3B) deamination activity on ssDNA is considered a contributing factor to tumor heterogeneity and drug resistance in a number of human cancers. Despite its clinical impact, little is known about A3B ssDNA substrate preference. We have used nuclear magnetic resonance to monitor the catalytic turnover of A3B substrates in real-time. This study reports preferred nucleotide sequences for A3B substrates, including optimized 4-mer oligonucleotides, and reveals a breadth of substrate recognition that includes DNA sequences known to be mutated in drug-resistant cancer clones. Our results are consistent with available clinical and structural data and may inform the design of substrate-based A3B inhibitors.
Insights
The study identified preferred DNA sequences for APOBEC3B (A3B) enzyme activity, which drives tumor heterogeneity and drug resistance. Understanding these A3B substrate preferences can help develop new cancer therapies.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- APOBEC3B (A3B) deamination activity on single-stranded DNA (ssDNA) contributes to tumor heterogeneity and drug resistance in various cancers.
- The specific substrate preferences of A3B remain largely uncharacterized, hindering therapeutic development.
Discussion:
- This study utilized nuclear magnetic resonance (NMR) to observe A3B's real-time catalytic turnover on ssDNA substrates.
- The research identified preferred nucleotide sequences for A3B, including optimized 4-mer oligonucleotides.
- A3B demonstrates broad substrate recognition, encompassing DNA sequences previously found mutated in drug-resistant cancer clones.
Key Insights:
- NMR-based real-time monitoring reveals A3B's ssDNA substrate sequence preferences.
- Identified preferred 4-mer oligonucleotide sequences for A3B activity.
- A3B recognizes DNA sequences associated with cancer drug resistance.
Outlook:
- Findings align with existing clinical and structural data on A3B.
- Results may guide the design of novel substrate-based A3B inhibitors for cancer treatment.
Related Concept Videos
¹³C NMR: ¹H–¹³C Decoupling
A broadband decoupling technique is used to simplify these complex, sometimes overlapping, signals. Broadband decoupling relies on a...
¹H NMR of Conformationally Flexible Molecules: Variable-Temperature NMR
Applications Of NMR In Biology
¹H NMR: Pople Notation
A proton...
Natural Selection and Mating Preferences
Females, due to their biological roles in conception, pregnancy, and nursing,...
Self-Evaluation: Self-Enhancement and Self-Verification

